PharmacoEthics Articles

PharmacoEthics.com

An EthicsWeb website

Ethical Issues in Pharmaceutical Drug Pricing

[Draft] Bibliography (1992-2004) by Trevor Coffrin

(under supervision of Dr. Chris MacDonald)

• Angell, Marcia. The Truth About the Drug Companies. (New York: Random House, 2004).

• Balasubramaniam, K. “Improving access to essential drugs for people living with HIV/AIDS,” Indian Journal of Medical Ethics. Available on-line at: http://www.issuesinmedicalethics.org/081or026.html

• Brody, Baruch, A. Ethical Issues in Drug Testing, Approval, and Pricing. (New York: Oxford University Press, 1995).

• Calfee, John E. “Pharmaceutical Price Controls and Patient Welfare,” Annals of Internal Medicine 2001, 134(11): 1060-1064, as appears at: http://www.issuesinmedicalethics.org/094oj132.html

• Carey, John, “What's a Fair Price for Drugs?” Business Week, April 30, 2001. p. 105.

• Chumney,  E.C.G. & Simpson, K. N. “The emerging role of the consumer in pharmaceutical pricing decisions,” Disease Management & Health Outcomes 2002, 10 (4): p. 229-232.

• Davidoff, Frank. “The heartbreak of drug pricing” Annals of Internal Medicine 2001, 134 (11): p. 1071, as appears at: http://www.issuesinmedicalethics.org/094oj132.html

• Dowell, William. “Ethics and AIDS drugs,” Time. New York: July 12, 1999, 154 (2):  p. 49.

• “Ethics Cannot Justify Fixing The Highest Prices For Medicines,” from http://www.catholicculture.org/docs/doc_view.cfm?recnum=3966

• GlaxoSmithKline “Facing The Challenge.” 2004. Available on-line at: http://www.gsk.com/community/downloads/FTC-TwoYearsOn.pdf

• Hammer, Peter, J. “Differential pricing of essential aids drugs,” Journal of International Economic Law. Oxford: December 2002, 5 (4): p. 883.

• Haugh, Richard. “Getting the attention of big pharma,” Hospitals & Health Networks. Chicago: October 2003, 77 (10):  p. 44.

• “Investors asked to assess firms on ethics,” (Manifest monthly newsletter, September 2002), available at: http://www.manifest.co.uk/manifest_i/2002/0209Sep/020907drugs.htm

• Light, Donald & Lexchin, Joel, “Will Lower Drug Prices Jeopardize Drug Research? A Policy Fact Sheet.” The American Journal of Bioethics 2004, 4(1): W1-W4. Available on-line at: http://www.bioethics.net/journal/j_articles.php?aid=61

• Mahan, Dee. “Profiting from Pain: Where Prescription Drug Dollars go,” from http://www.familiesusa.org/site/DocServer/PReport.pdf?docID=249

• Maitland, Ian. “Priceless goods: How should life-saving drugs be priced?” Business Ethics Quarterly. Chicago, October 2002, 12 (4): p. 451.

• Nakagawa, Bob. “More the Same Than Different,” Journal of Ambulatory Care Management, July-September 2004, 27 (3): p. 194-202.

• Oxfam, Save the Children, and VSO, “Beyond Philanthropy: the pharmaceutical industry, corporate social responsibility and the developing world,” 2002. Available on-line at: http://www.savethechildren.org.uk/temp/scuk/cache/cmsattach/622_beyondphil.pdf

• Plitch, Phyllis. “Religious Groups Invoke Holding Power To Press Drug Makers to Rein in Prices,” Wall Street Journal (Eastern edition) New York, N.Y. February 7, 2000. p. 1.

• Public Citizens Congress Watch, “Pharmaceuticals rank as most Profitable Industry, Again.” April 17^th, 2002. Available on-line at: http://www.citizen.org/documents/fortune500_2002erport.PDF

• Pujari, Sanjay. “Antiretroviles in India,” Indian Journal of Medical Ethics available on-line at: http://www.issuesinmedicalethics.org/061mi024.html

• Roberts, Mark J. “Notes on the Ethics of Drug Pricing,” from http://www.bio.org/events/2004/speaker/Commentary.pdf

• Rosin, Leah J. “Are pharmaceutical prices just? A discussion of business, values, and ethics” Available on-line at: http://pharmalicensing.com/articles/disp/1080562872_406814b87105d

• Schüklenk, Udo & Ashcroft, Richard E. “Affordable Access to Essential Medication in Developing Countries,” Journal of Medicine and Philosophy. April 2002, 27 (2): p.179-196.

• Spinello, Richard, A. “Ethics, Pricing and the Pharmaceutical Industry,” Journal of Business Ethics August 1992, 11 (8): p. 617-627.

• “Swiss-pharma-AIDS-ethics,” Agence France-Presse. February 3, 2003. Available on-line at: http://www.aegis.com/news/afp/2003/AF030235.html

• White, Ronald, F. & Fraley, Sean. “Imperfect Competition, Price-Fairness, and the Pharmaceutical Industry.” Available on-line at: http://www.stthom.edu/cbes/imperfection.html

• Wechsler, J. “Key issues emerge surrounding pharmaceutical pricing,” Formulary July 2004, 39 (7): p. 370-371.

• Xia, Lan; Monroe, Kent, B; Cox, Jennifer, L. “The Price Is Unfair! A Conceptual Framework of Price Fairness Perceptions,” Journal of Marketing. Chicago: October 2004, 68 (4): p. 1.